Literature DB >> 6577695

HLA and nasopharyngeal carcinoma in North American Caucasoids.

S B Moore, G R Pearson, H B Neel, L H Weiland.   

Abstract

In Chinese, nasopharyngeal carcinoma (NPC) has been associated with HLA alleles. Twenty-four Caucasoids with NPC were HLA typed (24 AB, 16 DR). No associations were found in comparisons with normal healthy controls.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6577695     DOI: 10.1111/j.1399-0039.1983.tb01168.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  7 in total

1.  Pathobiology of selected tumors of the base of the skull.

Authors:  L Barnes
Journal:  Skull Base Surg       Date:  1991

Review 2.  The biology and pathology of selected skull base tumors.

Authors:  L Barnes; S B Kapadia
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 3.  The human leukocyte antigen class I genes in nasopharyngeal carcinoma risk.

Authors:  Elham Hassen; Ghandri Nahla; Noureddine Bouaouina; Lotfi Chouchane
Journal:  Mol Biol Rep       Date:  2009-05-17       Impact factor: 2.316

4.  HLA association with nasopharyngeal carcinoma in southern Tunisia.

Authors:  Hafedh Makni; Jamel Daoud; Hanène Ben Salah; Nedia Mahfoudh; Olfa Haddar; Héla Karray; Tahya Boudawara; Abdelmonême Ghorbel; Abdelmajid Khabir; Mounir Frikha
Journal:  Mol Biol Rep       Date:  2009-08-28       Impact factor: 2.316

5.  Further evidence for an HLA-related recessive mutation in nasopharyngeal carcinoma among the Chinese.

Authors:  S P Hu; N E Day; D R Li; R N Luben; K L Cai; T Ou-Yang; B Li; X Z Lu; B A J Ponder
Journal:  Br J Cancer       Date:  2005-03-14       Impact factor: 7.640

Review 6.  HLA associations with nasopharyngeal carcinoma.

Authors:  Xin Li; Ross Fasano; Ena Wang; Kai-Tai Yao; Francesco M Marincola
Journal:  Curr Mol Med       Date:  2009-08       Impact factor: 2.222

7.  HLA and nasopharyngeal carcinoma in Malays.

Authors:  S H Chan; C T Chew; U Prasad; G B Wee; N Srinivasan; N Kunaratnam
Journal:  Br J Cancer       Date:  1985-03       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.